SCHEMBL23360307

SCHEMBL23360307

CC(C)(C)OC(=O)N1CCC(Nc2cccc3ncccc23)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.51
GPR119 Q8TDV5 4/20 0.50
NPC1 O15118 1/20 0.50
MAPT P10636 1/20 0.50
MAPK1 P28482 1/20 0.50
HTT P42858 1/20 0.50
RAB9A P51151 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
POLB P06746 1/20 0.48
CNR1 P21554 1/20 0.48
DTYMK P23919 1/20 0.47
CCNA2 P20248 1/20 0.47
CDK2 P24941 1/20 0.47
BRD4 O60885 1/20 0.46
NOS2 P35228 1/20 0.46
PIM1 P11309 1/20 0.46
PIM2 Q9P1W9 1/20 0.46
TRPV1 Q8NER1 1/20 0.46
DYRK1A Q13627 1/20 0.45
MEN1 O00255 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28952019 0.94 USP30 (0.50) ALDH1A1GPR119POLBBRD4PIM1
SCHEMBL29862610 0.94 USP30 (0.50) ALDH1A1GPR119POLBBRD4PIM1
SCHEMBL29862968 0.94 USP30 (0.50) ALDH1A1GPR119POLBBRD4PIM1
SCHEMBL28834054 0.94 USP30 (0.50) ALDH1A1GPR119POLBBRD4PIM1
SCHEMBL28834056 0.94 USP30 (0.50) ALDH1A1GPR119POLBBRD4PIM1
SCHEMBL29862513 0.93 ALDH1A1 (0.52) ALDH1A1GPR119NPC1MAPTMAPK1
SCHEMBL1880284 0.93 ALDH1A1 (0.52) ALDH1A1GPR119NPC1MAPTMAPK1
SCHEMBL28834375 0.86 USP30 (0.52) ALDH1A1GPR119CNR1BRD4PIM1
SCHEMBL28834190 0.86 USP30 (0.52) ALDH1A1GPR119CNR1BRD4PIM1
SCHEMBL28834189 0.86 USP30 (0.52) ALDH1A1GPR119CNR1BRD4PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4055014-B1 PYRROLIDINE AND PIPERIDINE COMPOUNDS YUHAN CORP (KR) 2025-04-30 EP disclosed
CN-114867719-B Pyrrolidine and piperidine compounds 柳韩洋行 2024-06-25 CN disclosed
US-11655235-B2 Pyrrolidine and piperidine compounds YUHAN CORPORATION (KR) 2023-05-23 US disclosed
EP-4055014-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS Yuhan Corporation (KR) 2022-09-14 EP disclosed
CN-114867719-A Pyrrolidine and piperidine compounds 柳韩洋行 2022-08-05 CN disclosed
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS YUHAN CORPORATION (KR) 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11655235-B2 Pyrrolidine and piperidine compounds FAP, APC, VHL ALDH1A1 439/4885GPR119 1940/4885NPC1 2057/4885
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS FAP, APC, VHL ALDH1A1 439/4885GPR119 1940/4885NPC1 2057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.